Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11.

OBJECTIVE To evaluate the incidence of morbidity, mortality, and disease control for patients requiring salvage total laryngectomy (TL) following organ preservation therapy. DESIGN Patients entered into a 3-arm randomized prospective multi-institutional trial for laryngeal preservation who required TL following initial treatment. SETTING The Radiation Therapy Oncology Group 91-11 trial for laryngeal preservation. PATIENTS From 1992 to 2000, 517 evaluable patients were randomized to receive chemotherapy followed by radiation therapy (arm 1), concomitant chemotherapy and radiation therapy (arm 2), or radiation therapy alone (arm 3). RESULTS Overall, TL was required in 129 patients. The incidence was 28%, 16%, and 31% in arms 1, 2, and 3, respectively (P =.002). Of these, 7 patients (5%) required TL for aspiration or necrosis. Following TL, the incidence of major and minor complications ranged from 52% to 59% and did not differ significantly among the 3 arms. Pharyngocutaneous fistula was lowest in arm 3 (15%) and highest in arm 2 (30%) (P>.05). There was 1 perioperative death. Local-regional control following salvage TL was 74% for arms 1 and 2 and 90% for arm 3. At 24 months, the overall survival was 69% (arm 1), 71% (arm 2), and 76% (arm 3) (P>.73). CONCLUSIONS Laryngectomy following organ preservation treatment is associated with acceptable morbidity. Perioperative mortality is low but up to one third of patients will develop a pharyngocutaneous fistula. Local-regional control is excellent for this group of patients. Survival following salvage TL was not influenced by the initial organ preservation treatment.

[1]  G. Calais,et al.  [Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy]. , 2000, Bulletin du cancer.

[2]  W. Goodwin Salvage Surgery for Patients With Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract: When Do the Ends Justify the Means? , 2000, The Laryngoscope.

[3]  M. Secic,et al.  Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck , 2000, Cancer.

[4]  A. Huang,et al.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. , 1998, The New England journal of medicine.

[5]  M. Strome,et al.  Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. , 1998, Archives of otolaryngology--head & neck surgery.

[6]  M. Leblanc,et al.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  W. Regine,et al.  Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. , 1997, International journal of radiation oncology, biology, physics.

[8]  W. Fee,et al.  Surgical Morbidity of Neck Dissection after Chemoradiotherapy in Advanced Head and Neck Cancer , 1997, The Annals of otology, rhinology, and laryngology.

[9]  G. Wolf,et al.  Surgery after organ preservation therapy. Analysis of wound complications. , 1995, Archives of otolaryngology--head & neck surgery.

[10]  W. Hong,et al.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.

[11]  S. Miller,et al.  Healing in the irradiated wound. , 1990, Clinics in plastic surgery.

[12]  Sudeep Sarkar,et al.  Complications following surgery for cancer of the larynx and pyriform fossa , 1990, Journal of surgical oncology.

[13]  J. Overgaard,et al.  Pharyngo‐cutaneous fistulae after laryngectomy. Influence of previous radiotherapy and prophylactic metronidazole , 1988, Cancer.

[14]  R. Metson,et al.  Surgical complications following twice‐a‐day versus once‐a‐day radiation therapy , 1988, The Laryngoscope.

[15]  W. F. Van den Bogaert,et al.  Are postoperative complications more frequent and more serious after irradiation for laryngeal and hypopharyngeal cancer? , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  R. Marx,et al.  The use of hyperbaric oxygen therapy in bony reconstruction of the irradiated and tissue-deficient patient. , 1982, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[17]  D. L. Joseph,et al.  Risks of head and neck surgery in previously irradiated patients. , 1973, Archives of otolaryngology.

[18]  J. Tortochaux,et al.  Cancers de l'oropharynx de stades III et IV : résultats d'une étude randomisée du Gortec comparant radiothérapie exclusive et radiothérapie avec chimiothérapie concomitante , 2000 .

[19]  A. Garden,et al.  A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. , 2000, International journal of radiation oncology, biology, physics.

[20]  Jay S. Cooper,et al.  A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 , 1999 .